Browse studies

Find your next paid study

78 recruiting studies matching your filters

Locomotor Training With Testosterone to Promote Bone and Muscle Health

This pilot study will determine the feasibility of implementing a combinatory rehabilitation strategy involving testosterone replacement therapy (TRT) with loc…

Spinal Cord InjurySpinal Cord InjuriesTrauma, Nervous System+17 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

North Florida Foundation for Research and EducationNCT04460872

Phase 1

A Phase 1/1b Study of Autologous b7-h3 Chimeric Antigen Receptor t Cells (b7-h3.cd28z.Cart) in Children and Young Adults With Recurrent or Progressive Cns Neoplasms Expressing b7-h3 Target

The purpose of this research study is to test the safety and effectiveness of a cell therapy at different doses for children and young adults with recurrent or…

Central Nervous System NeoplasmsBrain TumorBrain Tumor, Recurrent+11 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Robbie MajznerNCT07390539

ObservationalRemote eligible

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

The goal of this clinical trial is two-fold. First to investigate the feasibility of whether a remotely administered smartphone app can increase the volume and…

Parkinson DiseaseProdromal StageNeurodegenerative Diseases+8 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Radboud University Medical CenterNCT06993142

Study of Human Brain-Gut Axis and Gut Microbiome In Patients With Brain Lesions - Repository for Neuroscience Research

This study explores how microorganisms in the gut can affect the growth and progression of brain tumors.

Malignant Central Nervous System Neoplasm

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT06117930

Phase 2

Zanubrutinib With Pemetrexed for the Treatment of Relapsed/Refractory Primary and Secondary CNS Lymphomas: A Phase II Trial With a Safety Lead-In

This study is being conducted to evaluate the safety and efficacy of the combination of pemetrexed and zanubrutinib (called induction therapy) followed by zanu…

Primary Central Nervous System LymphomaSecondary Central Nervous System LymphomaRelapsed Cancer+1 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Baptist Health South FloridaNCT05681195

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical tria…

Cancer, MetastaticCancerCancer of Pancreas+40 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Phase 1

A Phase 1 Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ATI-105 in Healthy Adults

The goal of this clinical trial is to learn how ATI-105 administered to healthy participants at works in the body at different doses and with or without food. …

Friedreich AtaxiaCardiomyopathiesCentral Nervous System Diseases+4 more

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Adjuvia Therapeutics, Inc.NCT07869654

Genomes for Kids (G4K)

The development of next generation sequencing (NGS) techniques, including whole genome (WGS), exome (WES) and RNA sequencing has revolutionized the ability of …

Solid, Liquid, Central Nervous System Tumors

Estimated

~$10 – $750

Actual pay is set by the research site.

St. Jude Children's Research HospitalNCT02530658

Phase 1

Phase I Pilot Trial of Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas

This research study is for people who have been diagnosed with large B-cell lymphoma of the central nervous system (CNS), which has either returned or is not r…

Large B-cell LymphomaCentral Nervous System Lymphoma

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Allison WinterNCT07608731

Phase 1

A Phase I/II Study of Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma

This is a single arm open-label multicenter phase I/II investigation of combination lenalidomide/Tafasitamab in patients with relapsed central nervous system (…

CNS LymphomaPrimary Central Nervous System LymphomaSecondary Central Nervous System Lymphoma

Estimated

~$150 – $4,500

Actual pay is set by the research site.

James RubensteinNCT05351593

Phase 2

The Feasibility of Steady State CBV Mapping Using Ferumoxytol Immediately After Gadolinium Enhanced MRI of the CNS

This phase II trial studies how well gadolinium and ferumoxytol magnetic resonance imaging (MRI) work in diagnosing patients with abnormalities in the central …

Central Nervous System NeoplasmCranial Nerve DisorderMetastatic Malignant Neoplasm in the Brain

Estimated

~$75 – $3,000

Actual pay is set by the research site.

OHSU Knight Cancer InstituteNCT03270059

Phase 1

Robust Armored Dual-Cytokine (IL-15/IL-21) GPC3-CAR T Cells for Atypical Teratoid Rhabdoid Tumors and Central Nervous System Rhabdoid Tumors (RADIANT)

This study is being conducted in patients with GPC3-positive brain tumors that have recurred or have not responded to standard therapy. Atypical teratoid rhabd…

Atypical Teratoid Rhabdoid TumorCentral Nervous System Rhabdoid Tumor

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Baylor College of MedicineNCT07513194